๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Genetic Eye Disease

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD) NCT07502664n/a1 site๐Ÿ“ Irvine Ray Therapeutics, Inc. BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy NCT04912843Phase 2, Phase 31 site๐Ÿ“ Beijing Wuhan Neurophth Biotechnology Limited Company ยท Tests: NR082 injection, Sham Injection Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease NCT07262476Phase 31 site๐Ÿ“ Shanghai Minghui Pharmaceutical (Hangzhou) Ltd ยท Tests: MHB018A injection Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy NCT06590220n/a1 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study NCT06217588n/a1 site๐Ÿ“ Philadelphia University of Pennsylvania ยท Tests: Demographics, diagnosis type, genotype, lipid profile, renal function profile, treatment allocation, ophthalmology examโ€ฆ The CurePSP Genetics Program NCT06647641n/a1 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Whole genome sequencing will be performed at the NIH Clinical Trial Readiness for the Dystroglycanopathies NCT00313677n/a1 site๐Ÿ“ Iowa City Katherine Mathews Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study NCT05361720Phase 26 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ Cleveland Vanderbilt-Ingram Cancer Center ยท Tests: Cabozantinib, Ipilimumab, Nivolumab Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease NCT07480720n/a1 site๐Ÿ“ ElรขzฤฑฤŸ Elazฤฑg Fethi Sekin Sehir Hastanesi Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease NCT07439887Phase 1, Phase 23 sites๐Ÿ“ Bakersfield๐Ÿ“ Pittsburgh๐Ÿ“ Bellaire Ray Therapeutics, Inc. ยท Tests: RTx-021 Shanghai High Myopia Study NCT03062085n/a1 site๐Ÿ“ Shanghai Shanghai High Myopia Study Group ยท Tests: Cataract Vasculitis Pregnancy Registry NCT02593565n/a1 site๐Ÿ“ Tampa University of Pennsylvania ยท Tests: Online questionnaires Prognosis of Posterior Lamellar Keratoplasty NCT06859411n/a1 site๐Ÿ“ Metz Centre Hospitalier Rรฉgional Metz-Thionville ยท Tests: visual acuity comparaison A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions NCT07734064Phase 14 sites๐Ÿ“ Phoenix๐Ÿ“ Southaven๐Ÿ“ Cincinnati Astellas Institute for Regenerative Medicine ยท Tests: ASP2020 Descemet Endothelial Thickness Comparison Trial II NCT05275972Phase 38 sites๐Ÿ“ Palo Alto๐Ÿ“ Sacramento๐Ÿ“ Palm Beach Gardens Stanford University ยท Tests: Ripasudil, Placebo The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery NCT06048380Phase 31 site๐Ÿ“ Singapore Singapore Eye Research Institute ยท Tests: Ripasudil, Placebo Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity NCT07674290Phase 41 site๐Ÿ“ Essen Tom Hรผhne ยท Tests: Setmelanotide Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration NCT07064759Phase 3126 sites๐Ÿ“ Scottsdale๐Ÿ“ Sun City๐Ÿ“ Tucson 4D Molecular Therapeutics ยท Tests: 4D-150 IVT (3E10 vg/eye), EYLEAยฎ (aflibercept) Injection 2 mg (0.05mL) SUCCESS Score Validation in Fuchs Dystrophy NCT07265388n/a1 site๐Ÿ“ Madrid Instituto Ramรณn y Cajal de Investigaciรณn Sanitaria ยท Tests: Phacoemulsification Cataract Surgery Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa NCT06591793Phase 1, Phase 23 sites๐Ÿ“ Naples๐Ÿ“ London๐Ÿ“ London AAVantgarde Bio Srl ยท Tests: AAVB-081 Study of ALK-001 on the Progression of Stargardt Disease NCT07419334Phase 314 sites๐Ÿ“ Phoenix๐Ÿ“ Aurora๐Ÿ“ Gainesville Alkeus Pharmaceuticals, Inc. ยท Tests: ALK-001, Placebo Physical and Psychosocial Parameters in Takayasu Arteritis and Behรงet's Disease: A Comparative Study With Healthy Controls NCT07276087n/a1 site๐Ÿ“ Denizli ร–ZLEM NUR TOK YAMAN ยท Tests: No intervention (observational study) A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa NCT06891885Phase 1, Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Minneapolis Sumitomo Pharma America, Inc. ยท Tests: DSP-3077 Retinal Sheet Cohort 1, DSP-3077 Retinal Sheet Cohort 2, DSP-3077 Retinal Sheet Cohort 3 A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants NCT07836452Phase 11 site๐Ÿ“ Melbourne City Therapeutics ยท Tests: CITY-RBP4, Placebo Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa Genetics of Inherited Eye Disease NCT02471287n/a1 site๐Ÿ“ Bethesda National Eye Institute (NEI) Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France NCT05742321n/a1 site๐Ÿ“ Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne ยท Tests: Genotyping, Histology, Collection of data A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB) NCT06563414n/a1 site๐Ÿ“ Pittsburgh Krystal Biotech, Inc.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy